Cellspin Soft, Inc. v. Nike, Inc., No. 2:22-cv-00455 (E.D. Tex. Sept. 26, 2023)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Before the Court, defendant Nike, Inc., moves to transfer pursuant to 28 U.S.C. § 1404(a) to the Northern District of California (“NDCA”) or in the alternative to the District of Oregon. Dkt. No. 12. Having considered the motion, it is GRANTED. I. BACKGROUND Plaintiff Cellspin Soft, Inc. (“Cellspin”) filed its Complaint on November 23, 2022 asserting U.S. Patent Nos. 8,738,794; 8,892,752; a nd 9,749,847 (“the Asserted Patents”) against numerous Nike products referred to collectively as “Nike Adapt Wearable.” The instant Motion, Dkt. No.